These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10146879)

  • 1. Economic and quality-of-life aspects of treating small cell lung cancer.
    Graham P; Boyages J
    Pharmacoeconomics; 1993 Jun; 3(6):446-53. PubMed ID: 10146879
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic analyses and lung cancer.
    Vergnenègre A; Molinier L; Chouaïd C
    Monaldi Arch Chest Dis; 2001 Aug; 56(4):336-43. PubMed ID: 11770217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer cure, care, and cost: let the data be your guide.
    Kris MG
    J Clin Oncol; 1997 Sep; 15(9):3027-9. PubMed ID: 9294464
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost of treating small cell lung cancer.
    Rosenthal MA; Webster PJ; Gebski VJ; Stuart-Harris RC; Langlands AO; Boyages J
    Med J Aust; 1992 May; 156(9):605-10. PubMed ID: 1320729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counting costs of care.
    McVie JC
    J Clin Oncol; 1988 Oct; 6(10):1529-31. PubMed ID: 2845010
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment pathways, resource use and costs in the management of small cell lung cancer.
    Oliver E; Killen J; Kiebert G; Hutton J; Hall R; Higgins B; Bourke S; Paschen B
    Thorax; 2001 Oct; 56(10):785-90. PubMed ID: 11562518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life.
    Stephens R
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):483-97. PubMed ID: 15094183
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost of lung cancer in Turkey.
    Cakir Edis E; Karlikaya C
    Tuberk Toraks; 2007; 55(1):51-8. PubMed ID: 17401794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer management in limited resource settings: guidelines for appropriate good care.
    Macbeth FR; Abratt RP; Cho KH; Stephens RJ; Jeremic B;
    Radiother Oncol; 2007 Feb; 82(2):123-31. PubMed ID: 17239979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model.
    Chouaid C; Bassinet L; Fuhrman C; Monnet I; Housset B
    J Clin Oncol; 1998 Aug; 16(8):2700-7. PubMed ID: 9704720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life assessment in small cell lung cancer.
    Fayers P
    Pharmacoeconomics; 1992 Sep; 2(3):181-8. PubMed ID: 10147008
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost of lung cancer: a methodological review.
    Molinier L; Combescure C; Chouaïd C; Daurès JP; Housset B; Fabre D; Grand A; Vergnenègre A
    Pharmacoeconomics; 2006; 24(7):651-9. PubMed ID: 16802841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer.
    Holmes J; Dunlop D; Hemmett L; Sharplin P; Bose U
    Pharmacoeconomics; 2004; 22(9):581-9. PubMed ID: 15209527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and surgery versus surgery alone in non-small-cell lung cancer.
    McLachlan SA; Stockler M
    N Engl J Med; 1994 Jun; 330(24):1757. PubMed ID: 8043105
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer.
    Lakdawalla DN; Chou JW; Linthicum MT; MacEwan JP; Zhang J; Goldman DP
    JAMA Oncol; 2015 May; 1(2):196-202. PubMed ID: 26181023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Survival and quality of life in small cell anaplastic pulmonary carcinoma].
    Bonde JP; Christensen PB; Andersen FS; Lindrup JA
    Ugeskr Laeger; 1986 Dec; 148(51):3446-8. PubMed ID: 3027937
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: extended analysis of the PROSE trial.
    Hornberger J; Hirsch FR; Li Q; Page RD
    Lung Cancer; 2015 May; 88(2):223-30. PubMed ID: 25804732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives in the treatment of small cell lung cancer: educational symposium of the VII World Congress on Lung Cancer.
    Ihde DC
    Lung Cancer; 1995 Jun; 12 Suppl 3():S1-3. PubMed ID: 7551952
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of cancer chemotherapy: an economic evaluation of a randomized trial in small-cell lung cancer.
    Goodwin PJ; Feld R; Evans WK; Pater J
    J Clin Oncol; 1988 Oct; 6(10):1537-47. PubMed ID: 2845011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.